BrightSpring insider sells 15,099 shares at $57.91

BrightSpring’s PharMerica president exercised stock options and sold shares under a Rule 10b5-1 trading plan, including a 15,099-share sale.

Rhea-AI Filing Summary

BrightSpring Health Services, Inc. (BTSG) officer Scott A. Greenwell, President, PharMerica, reported option-related transactions on September 14, 2026 made under a Rule 10b5-1 trading plan. He exercised stock options for 11,973 shares of common stock at an exercise price of $22.27 per share and then sold 15,099 shares of common stock at $57.91 per share in a sale reported as an open market or private transaction. Following the exercise, he held 23,947 stock options directly, with those options vesting in three equal annual installments commencing on June 20, 2026.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Greenwell Scott A.

Role President, PharMerica

Sold 15,099 shs ($874K)

Approx. gross sale proceeds $874K

Approx. exercise cost $267K

Type	Security	Shares	Price	Value
Exercise	Stock Options (Right to Buy) F1	11,973	$0.00	$0.00
Exercise	Common Stock	11,973	$22.27	$267K
Sale	Common Stock	15,099	$57.91	$874K

Holdings After Transaction: Stock Options (Right to Buy) — 23,947 contracts (Direct); Common Stock — 31,246 shares (Direct)

Footnotes (1)

1. F1. Options vest in three equal annual installments commencing on June 20, 2026.

Key Figures

Options exercised: 11,973 shares Option exercise price: $22.27 per share Shares sold: 15,099 shares +4 more

7 metrics

Options exercised 11,973 shares Stock options exercised into common stock on September 14, 2026

Option exercise price $22.27 per share Exercise price for 11,973 stock options converted into common stock

Shares sold 15,099 shares Common stock sale reported on September 14, 2026

Sale price $57.91 per share Reported price for sale of 15,099 BrightSpring common shares

Remaining stock options 23,947 options Directly held options following the reported exercise

Option expiration date June 20, 2035 Expiration date for the exercised stock options

Vesting commencement June 20, 2026 Options vest in three equal annual installments from this date

Key Terms

Rule 10b5-1 trading plan, Stock Options (Right to Buy), derivative security, vesting

4 terms

Rule 10b5-1 trading plan regulatory

"transactions by Scott A. Greenwell were made under a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Stock Options (Right to Buy) financial

"security titled Stock Options (Right to Buy) was exercised for 11,973 shares"

derivative security financial

"transaction reported as an exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

vesting financial

"Options vest in three equal annual installments commencing on June 20, 2026"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did BrightSpring (BTSG) report for Scott A. Greenwell on this Form 4?

Scott A. Greenwell exercised 11,973 stock options for BrightSpring common stock at an exercise price of $22.27 per share and sold 15,099 shares of common stock at $57.91 per share on September 14, 2026, all reported as direct holdings.

Was the BrightSpring (BTSG) insider trading activity under a Rule 10b5-1 plan?

Yes. The filing indicates the transactions by Scott A. Greenwell were made under a Rule 10b5-1 trading plan, meaning the trades were carried out according to a pre-established plan rather than being timed at the insider’s discretion.

How many BrightSpring (BTSG) stock options did Scott A. Greenwell exercise and what was the strike price?

Scott A. Greenwell exercised 11,973 stock options for BrightSpring common stock at an exercise (conversion) price of $22.27 per share on September 14, 2026, converting those options into the same number of common shares.

What BrightSpring (BTSG) share sale did Scott A. Greenwell report on September 14, 2026?

He reported selling 15,099 shares of BrightSpring common stock at a reported price of $57.91 per share in a transaction described as a sale in an open market or private transaction, with the shares held directly.

How many BrightSpring (BTSG) stock options does Scott A. Greenwell hold after the reported exercise?

After exercising options, Scott A. Greenwell directly held 23,947 stock options on BrightSpring common stock. These options vest in three equal annual installments commencing on June 20, 2026, according to the filing’s footnote.

What is the vesting schedule of the BrightSpring (BTSG) options referenced in the Form 4?

The stock options referenced in the filing vest in three equal annual installments commencing on June 20, 2026. This schedule applies to the options tied to the derivative transaction reported for 11,973 underlying shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 04:05 PM Accepted by SEC EDGAR 09/16/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Greenwell Scott A.

(Last) (First) (Middle)

C/O BRIGHTSPRING HEALTH SERVICES, INC.

805 N. WHITTINGTON PARKWAY

(Street)

LOUISVILLE KENTUCKY 40222

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BrightSpring Health Services, Inc. [ BTSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, PharMerica

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/14/2026		M		11,973	A	$22.27	46,345	D
Common Stock	09/14/2026		S		15,099	D	$57.91	31,246	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$22.27	09/14/2026		M			11,973	(1)	06/20/2035	Common Stock	11,973	$0	23,947	D

Explanation of Responses:

1. Options vest in three equal annual installments commencing on June 20, 2026.

	/s/ Jennifer Phipps, as Attorney-in-Fact	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)